Annual Congress Berlin 2001

Saturday, 22.09.2001
Sunday, 23.09.2001
Monday, 24.09.2001
Tuesday, 25.09.2001
Wednesday, 26.09.2001

Citations should be made in the following way: Authors. Title. Eur Respir J 2004; 18: Suppl. 33, abstract number.

Material from 2001:

3025 Abstracts

Material from 2001: Show

Pulmonary hypertension: what's new?

Oral Presentation
Chairs: R. Naeije (Brussels, Belgium), L. P. Nicod (Geneva, Switzerland)

Download all media

Fractalkine and its receptor (CX3CR1) in primary pulmonary hypertension (PPH) P. Dorfmuller, K. Balabanian, A. Foussat, I. Durand-Gasselin, G. Simonneau, D. Emilie, M. Humbert (Clamart, France)
Value of pulmonary intravascular ultrasound in primary pulmonary hypertension B. Lara, A. Roman, E. Domingo, J. Rodes, V. Monforte, C. Bravo, F. Morell (Barcelona, Spain)
Sleep related breathing disorders (SRDB) in pulmonary hypertension. Effect of therapy M. Delcroix, M. Cauberghs, G. Verleden, M. Demedts, B. Buyse (Leuven, Belgium)
Elevated pulmonary capillary pressure in pulmonary arterial hypertension A. Pagnamenta, P. Fesler, J. L. Vachiery, S. Abdel Kafi, A. Boonstra, S. Brimioulle, R. Naeije (Brussels, Belgium; Amsterdam, The Netherlands)
The effect of perinatal hypoxic exposure in fawn hooded and wistar rats H. M. Marriott, E. J. R. van Beek, C. J. Emery (Sheffield, United Kingdom)
Angiotensin-converting enzyme gene polymorphism as a risk factor of high-altitude pulmonary hypertension in Kyrgyz highlanders A. A. Aldashev, A. S. Sarybaev, N. W. Morrell, B. B. Kalmyrzaev, E. V. Kim, A. S. Sydykov, B. K. Kojonazarov, L. B. Mamanova (Bishkek, Kyrgyzstan; Cambridge, United Kingdom)
The vasodilator response to inhaled nitric oxide (iNO) predicts the short term evolution with oral vasodilators in pulmonary arterial hypertension J. Morales, J. A. Barbera, E. Gavela, E. Sala, F. Burgos, A. Torres, M. Melgosa, S. Santos, J. Roca, R. Rodriguez-Roisin (Barcelona, Palma de Mallorca, Spain)